|
DEPDC4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66650004906899E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.65343302885412E-13 |
| Normal-vs-Stage2 |
2.09419999996907E-06 |
| Normal-vs-Stage3 |
6.00409999496065E-09 |
| Normal-vs-Stage4 |
2.83139955925549E-10 |
| Stage1-vs-Stage2 |
2.530000E-01 |
| Stage1-vs-Stage3 |
9.226800E-01 |
| Stage1-vs-Stage4 |
1.862580E-01 |
| Stage2-vs-Stage3 |
2.355200E-01 |
| Stage2-vs-Stage4 |
3.408000E-02 |
| Stage3-vs-Stage4 |
2.928200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.10829997904227E-09 |
| Normal-vs-AfricanAmerican |
4.0391000000195E-06 |
| Normal-vs-Asian |
7.6859999997847E-07 |
| Caucasian-vs-AfricanAmerican |
5.739000E-01 |
| Caucasian-vs-Asian |
4.448400E-01 |
| AfricanAmerican-vs-Asian |
2.835000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.95680005532495E-09 |
| Normal-vs-Female |
2.7670999935836E-09 |
| Male-vs-Female |
6.157600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.61830002123986E-09 |
| Normal-vs-Age(41-60Yrs) |
6.5882854727306E-12 |
| Normal-vs-Age(61-80Yrs) |
2.08439999704879E-08 |
| Normal-vs-Age(81-100Yrs) |
4.10550000000676E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.289200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.307800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.907800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.025200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.236400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.329600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.745200E-01 |
| Classical-VS-Follicular |
5.991200E-01 |
| Classical-VS-Other |
4.402000E-01 |
| Classical-VS-Normal |
5.03730002154867E-09 |
| Tall-VS-Follicular |
6.826000E-01 |
| Tall-VS-Other |
4.493600E-01 |
| Tall-VS-Normal |
5.06370000041834E-07 |
| Follicular-VS-Other |
1.499550E-01 |
| Follicular-VS-Normal |
1.04469999995249E-06 |
| Other-VS-Normal |
5.07129999993694E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.79200037825944E-10 |
| Normal-vs-N1 |
1.01310000388821E-08 |
| N0-vs-N1 |
8.297400E-01 |
|
|
